Spots Global Cancer Trial Database for BKM120 for Patients With PI3K-activated Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: BKM120 for Patients With PI3K-activated Tumors
Official Title: Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 1 - BKM120 for Patients With PI3K-activated Tumors
Study ID: NCT01833169
Conditions
Interventions
Study Description
Brief Summary: The purpose of this signal seeking study was is to determine whether treatment with BKM120 demonstrates sufficient efficacy in select pathway-activated solid tumors and/or hematologic malignancies to warrant further study.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Arizona Oncology Associates HOPE Division, Phoenix, Arizona, United States
Arizona Oncology Associates PC- HAL, Sedona, Arizona, United States
Highlands Oncology Group, Fayetteville, Arkansas, United States
Sarcoma Oncology Center, Santa Monica, California, United States
Rocky Mountain Cancer Centers RMCC - Aurora, Greenwood Village, Colorado, United States
Whittingham Cancer Center Norwalk Hospital, Norwalk, Connecticut, United States
Eastern Connecticut Hematology & Oncology Associates The Norwich Cancer Center, Norwich, Connecticut, United States
Florida Cancer Specialists Dept of Oncology (2), Fort Myers, Florida, United States
Florida Hospital Cancer Institute FL Hosp. Cancer Instit., Orlando, Florida, United States
Florida Cancer Specialists, West Palm Beach, Florida, United States
University Cancer & Blood Center, LLC, Athens, Georgia, United States
Southeastern Regional Medical Center, Newnan, Georgia, United States
Lurie Children's Hospital of Chicago Developmental Therapeutics, Chicago, Illinois, United States
Cancer Care Specialists of Central Illinois, Decatur, Illinois, United States
Illinois Cancer Care P.C. IL. Cancer Care, Peoria, Illinois, United States
Illinois Cancer Care P.C., Peoria, Illinois, United States
Cancer Treatment Centers of America Southwestern Regional Med. Ctr, Schaumburg, Illinois, United States
Northern Indiana Cancer Research Consortium No. Indiana Cancer Res., South Bend, Indiana, United States
University of Iowa Hospitals & Clinics Regulatory Contact 2, Iowa City, Iowa, United States
Eastern Maine Medical Center Research Center SC, Bangor, Maine, United States
Mount Auburn Hospital, Cambridge, Massachusetts, United States
Michigan Medicine University of Michigan Int. Medicine Oncology, Ann Arbor, Michigan, United States
Cancer and Hematology Centers of West Michigan Dept. of Oncology, Grand Rapids, Michigan, United States
Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology, Minneapolis, Minnesota, United States
Nebraska Cancer Specialists Oncology Hematology West, Omaha, Nebraska, United States
Comprehensive Cancer Centers, Las Vegas, Nevada, United States
Hematology Oncology Associates of Northern New Jersey PA Regional Cancer Care Assoc., Morristown, New Jersey, United States
Cancer Center at Presbyterian, Albuquerque, New Mexico, United States
New York Oncology Hematology NY Onc Hem, Albany, New York, United States
Waverly Hematology Oncology, Cary, North Carolina, United States
University of N C at Chapel Hill Physician Office Building, Chapel Hill, North Carolina, United States
Duke University Medical Center Seeley G. Mudd Bldg., Durham, North Carolina, United States
Cleveland Clinic Foundation Cleveland Clinic (19), Cleveland, Ohio, United States
Mid Ohio Oncology/Hematology Mark H. Zangmeister Center, Columbus, Ohio, United States
Bend Memorial Clinic Bend Mem. Clinic, Bend, Oregon, United States
Northwest Cancer Specialists Compass Oncology (36), Portland, Oregon, United States
Oregon Health and Science University Oregon Health & Science U (56), Portland, Oregon, United States
Salem Health, Salem, Oregon, United States
Gettysburg Cancer Center, Gettysburg, Pennsylvania, United States
West Penn Allegheny Oncology Network, Natrona Heights, Pennsylvania, United States
University of Pittsburgh Medical Center UPMC, Pittsburgh, Pennsylvania, United States
Abington Hematology Oncology Associates, Inc Abington Hem Onc Assoc (5), Willow Grove, Pennsylvania, United States
Sanford University of South Dakota Medical Center Sanford Health, Sioux Falls, South Dakota, United States
Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology, Chattanooga, Tennessee, United States
West Cancer Clinic, Memphis, Tennessee, United States
Sarah Cannon Research Institute, Nashville, Tennessee, United States
Texas Oncology P A Round Rock, Dallas, Texas, United States
Texas Oncology Sammons Cancer Center Sammons Cancer Center (10), Dallas, Texas, United States
Texas Oncology, P.A. Texas Oncololgy, P.A. (8), Fort Worth, Texas, United States
Oncology Consultants Oncology Group, Houston, Texas, United States
MD Anderson Cancer Center/University of Texas MD Anderson Cancer Center (3), Houston, Texas, United States
Cancer Care Centers of South Texas HOAST CCC of So. TX-San Antonio (3), San Antonio, Texas, United States
Tyler Cancer Center, Tyler, Texas, United States
Intermountain Medical Center Intermountain Healthcare, Murray, Utah, United States
Virginia Cancer Specialists Virginia Cancer Specialists, Fairfax, Virginia, United States
Blue Ridge Research Center at Roanoke Neurological Center McKesson Specialty Care, Roanoke, Virginia, United States
Kadlec Clinic Hematology and Oncology Kadlec Clinic Hematology & Onc, Kennewick, Washington, United States
Northwest Medical Specialties Hematology/Oncology, Tacoma, Washington, United States
Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin, United States
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
